Form 4: MicroVision Director Robert Carlile Reports Vesting of 20,112 Shares and Grant of 87,642 New Restricted Stock Units
Insider Transaction Report
MicroVision, Inc. Director Robert Paul Carlile reported the vesting of 20,112 restricted stock units into common stock and the grant of 87,642 new restricted stock units, increasing his total beneficial ownership of common stock to 284,778 shares.
Summary
- Robert Paul Carlile, a Director of MicroVision, Inc. (MVIS), reported changes in his beneficial ownership of company securities.
- On June 5, 2025, 20,112 restricted stock units (RSUs) vested and converted into an equal number of common shares, without payment. These RSUs were originally granted on June 5, 2024.
- Following this vesting, Mr. Carlile's direct beneficial ownership of common stock increased to 284,778 shares.
- On June 6, 2025, Mr. Carlile was granted an additional 87,642 restricted stock units.
- These newly granted RSUs are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on his continued service as a director.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as it reflects a director's continued equity compensation and increased direct ownership, aligning their interests with the company. It's a routine compensation event, not indicative of major strategic shifts, but generally viewed favorably as it shows commitment.
Positives
- The vesting of 20,112 restricted stock units (RSUs) into common stock for Director Robert Paul Carlile represents a direct increase in his equity stake in MicroVision, Inc.
- The grant of an additional 87,642 new restricted stock units to Mr. Carlile demonstrates continued compensation and alignment of interests between the director and the company's long-term performance.
- The increase in Mr. Carlile's total beneficial ownership of common stock to 284,778 shares after the vesting transaction indicates a significant personal investment in the company's future.
Negatives
- The vesting and grant of restricted stock units, while common compensation practices, can lead to minor share dilution over time as new shares are issued.
Risks
- The vesting of future restricted stock units is contingent upon the reporting person's continued service as a director, meaning forfeiture could occur if service ceases before vesting dates.
Future Outlook
The document indicates future vesting events for the newly granted 87,642 Restricted Stock Units, which are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date (June 6, 2026) or the day prior to MicroVision's 2026 Annual Meeting of Stockholders, provided Mr. Carlile continues his service as a director.
Industry Context
This Form 4 filing reflects a routine insider compensation event (vesting and new grant of equity) for a director of MicroVision, Inc. Such transactions are common across publicly traded companies as a means of aligning executive and director interests with shareholder value through equity-based compensation.
Comparison to Industry Standards
- Equity compensation for directors, often in the form of restricted stock units, is a standard practice across industries, including the technology and automotive lidar sectors where MicroVision operates.
- The structure of vesting over time, contingent on continued service, is typical for retaining key personnel and aligning their long-term interests with company performance.
- Specific comparable companies like Luminar Technologies (LAZR) or Velodyne Lidar (VLDR, now part of Ouster) also utilize similar equity compensation plans for their directors and executives, though the specific number of units and vesting schedules would vary based on company size, compensation philosophy, and individual roles.
Related Party Transactions
- The vesting of 20,112 Restricted Stock Units and the grant of 87,642 new Restricted Stock Units to Director Robert Paul Carlile represent related party transactions as they involve compensation from the company to a member of its board of directors.
Stakeholder Impact
- Shareholders: The vesting and grant of RSUs may result in minor dilution as new shares are issued, but also aligns the director's interests with shareholder value.
- Director (Robert Paul Carlile): Directly benefits from increased equity ownership and future compensation, strengthening his financial stake in the company's success.
Next Steps
- Future vesting of 87,642 Restricted Stock Units in four equal quarterly installments, contingent on continued service.
- Full vesting of the 87,642 RSUs is expected by the earlier of June 6, 2026, or the day prior to MicroVision's 2026 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 06/05/2024 | Grant date of 20,112 Restricted Stock Units that vested on 06/05/2025. |
| 06/05/2025 | Date of transaction for the vesting of 20,112 Restricted Stock Units into common stock. |
| 06/05/2025 | Expiration date for the 20,112 Restricted Stock Units that vested. |
| 06/06/2025 | Date of transaction for the grant of 87,642 new Restricted Stock Units. |
| 06/06/2025 | Signature date of the reporting person's attorney-in-fact. |
| 2025 Annual Meeting of Stockholders | Earliest potential full vesting date for RSUs granted on 06/05/2024. |
| 2026 Annual Meeting of Stockholders | Earliest potential full vesting date for RSUs granted on 06/06/2025. |
Keywords
MicroVision, MVIS, Form 4, SEC filing, insider transaction, restricted stock units, RSU, beneficial ownership, director compensation, equity grant, stock vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.